Zeinab Karimimoghadam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zeinab Karimimoghadam has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Reza Tabrizi
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
2 shared publications - Abdulhakeem Alkamel
Clinical Research Development Unit, Valiasr Hospital, Fasa University of Medical Sciences, Fasa, Iran
1 shared publication Faezeh Mobasheri-Shiri
Department of Environmental Health Engineering, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication- Fatemeh Sarvi
Department of Public Health, School of Health, Larestan University of Medical Sciences, Larestan, Iran
1 shared publication - Mahdi Ravankhah
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Mahmoud Khodadost
Department of Public Health, School of Health, Larestan University of Medical Sciences, Larestan, Iran
1 shared publication
Latest Publications
- 13 October 2025
- Published by Elsevier in Environmental Research
- Vol. 287, 123064
Associations between exposure to air pollutants and QT interval change: A comprehensive systematic review
- 13 October 2025
- Published by Elsevier in Environmental Research
- Vol. 287, 123064
Associations between exposure to air pollutants and QT interval change: A comprehensive systematic review
- 4 September 2024
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (10) , 1113-1122
The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis
Introduction Heart failure (HF) is a significant worldwide concern due to its substantial impact on mortality rates and recurrent hospitalizations. The relationship between recurrent hospitalizations and mortality in individuals diagnosed with heart failure has been the subject of conflicting findings in previous studies. A meta-analysis was conducted to investigate the association between recurrent heart failure hospitalizations (HFHs) and mortality. Methods We conducted a systematic search across various online databases, such as PubMed, Embase, Web of Science, ProQuest, Scopus, Science Direct, and Google Scholar, to locate studies that examined the connection between recurrent HFHs and cardiovascular (CV) mortality as well as all-cause mortality until January 2023. To evaluate the heterogeneity among the studies, we employed I2 and Cochran’s Q test. Results In total, 143,867 participants from seven studies were included in the analysis. Recurrent HFHs were found to be strongly associated with elevated risks of both cardiovascular (CV) mortality and all-cause mortality. The pooled hazard ratios (HRs) indicated a non-significant association for CV mortality (HR = 4.28, 95% CI: 0.86–7.71) but a significant association for all-cause mortality (HR = 2.76, 95% CI: 2.05–3.48). Subgroup analyses revealed a reduction in heterogeneity when stratified by factors such as quality score, sample size, hypertension comorbidity, number of recurrent HFHs, and follow-up time. A clear correlation was observed between the frequency of HFH and the mortality risk. Various subgroups, including those with diabetes, atrial fibrillation, and chronic kidney disease, showed significant associations between recurrent HFHs and all-cause mortality. Additionally, recurrent HFHs were significantly associated with CV mortality in subgroups such as heart failure with reduced ejection fraction (HFrEF), atrial fibrillation, and diabetes. Conclusion This meta-analysis provides evidence of an association between recurrent HFH and elevated risk of both CV mortality and all-cause mortality. The findings consistently indicate that a higher frequency of HFH is strongly associated with an increased likelihood of mortality.
- 4 September 2024
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (10) , 1113-1122
The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis
Introduction Heart failure (HF) is a significant worldwide concern due to its substantial impact on mortality rates and recurrent hospitalizations. The relationship between recurrent hospitalizations and mortality in individuals diagnosed with heart failure has been the subject of conflicting findings in previous studies. A meta-analysis was conducted to investigate the association between recurrent heart failure hospitalizations (HFHs) and mortality. Methods We conducted a systematic search across various online databases, such as PubMed, Embase, Web of Science, ProQuest, Scopus, Science Direct, and Google Scholar, to locate studies that examined the connection between recurrent HFHs and cardiovascular (CV) mortality as well as all-cause mortality until January 2023. To evaluate the heterogeneity among the studies, we employed I2 and Cochran’s Q test. Results In total, 143,867 participants from seven studies were included in the analysis. Recurrent HFHs were found to be strongly associated with elevated risks of both cardiovascular (CV) mortality and all-cause mortality. The pooled hazard ratios (HRs) indicated a non-significant association for CV mortality (HR = 4.28, 95% CI: 0.86–7.71) but a significant association for all-cause mortality (HR = 2.76, 95% CI: 2.05–3.48). Subgroup analyses revealed a reduction in heterogeneity when stratified by factors such as quality score, sample size, hypertension comorbidity, number of recurrent HFHs, and follow-up time. A clear correlation was observed between the frequency of HFH and the mortality risk. Various subgroups, including those with diabetes, atrial fibrillation, and chronic kidney disease, showed significant associations between recurrent HFHs and all-cause mortality. Additionally, recurrent HFHs were significantly associated with CV mortality in subgroups such as heart failure with reduced ejection fraction (HFrEF), atrial fibrillation, and diabetes. Conclusion This meta-analysis provides evidence of an association between recurrent HFH and elevated risk of both CV mortality and all-cause mortality. The findings consistently indicate that a higher frequency of HFH is strongly associated with an increased likelihood of mortality.